Appointment booking for Dr. Wesley Girod, M D is currently not available.Dr. Wesley Girod, M D has not yet fully activated their profile on DiabetesIQ.
Dr. Wesley Girod, M D (he/him) is a Surgeon in Hattiesburg, MS with over 18 years of experience. What is your opinion of Dr. Wesley Girod, M D? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Wesley Girod, M D has received over $25,791 which includes payments from the following companies:
$19,581.67 from Intuitive Surgical, Inc.
$3,548.42 from APOLLO ENDOSURGERY INC
$721.52 from Ethicon US, LLC
$399.00 from LifeCell Corporation
$318.96 from Allergan Inc.
$180.33 from Davol Inc.
$82.75 from Mallinckrodt LLC
$82.58 from TOLMAR Pharmaceuticals, Inc.
$76.89 from Covidien Sales LLC
$69.37 from Retrophin, Inc.
$60.00 from Baxter Healthcare
$59.25 from Cook Incorporated
$47.81 from Mission Pharmacal Company
$47.66 from Endo Pharmaceuticals Inc.
$43.05 from AngioDynamics, Inc.
$38.33 from Rochester Medical Corporation
$36.66 from Dendreon Pharmaceuticals LLC
$31.65 from Covidien LP
$28.85 from Novadaq Technologies Inc.
$27.78 from Shire North American Group Inc
Payments received by Dr. Wesley Girod, M D were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!